Carbidopa is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Carbidopa.
| Product ID | 59651-146_b39dd4bd-2e81-444b-8fb8-ecaafab742cb |
| NDC | 59651-146 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Carbidopa |
| Generic Name | Carbidopa |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-10-21 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211055 |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | CARBIDOPA |
| Active Ingredient Strength | 25 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-10-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA211055 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| CARBIDOPA | 25 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16714-067 | Carbidopa | Carbidopa |
| 40032-980 | Carbidopa | Carbidopa |
| 42799-123 | Carbidopa | Carbidopa |
| 43386-980 | Carbidopa | Carbidopa |
| 43975-220 | Carbidopa | Carbidopa |
| 51407-314 | Carbidopa | Carbidopa |
| 59651-146 | Carbidopa | Carbidopa |
| 63629-1932 | Carbidopa | Carbidopa |
| 63629-9193 | Carbidopa | Carbidopa |
| 68682-200 | Carbidopa | Carbidopa Tablets |
| 70710-1221 | CARBIDOPA | CARBIDOPA |
| 70771-1355 | CARBIDOPA | CARBIDOPA |
| 25010-711 | Lodosyn | carbidopa |